Therefore, in order to evaluate the interplay between leptin levels and the pathophysiology of EDs, as well as the treatment implications, it is necessary to clarify the variations in leptin across different EDs, accounting for various confounding factors, and their persistence after recovery. The gene discussed is LEP; the disease is Ehlers-Danlos syndrome.